QIAGEN to Return $300M to Shareholders via Synthetic Repurchase

Ticker: QGEN · Form: 6-K · Filed: Jan 13, 2025 · CIK: 1015820

Qiagen N.V. 6-K Filing Summary
FieldDetail
CompanyQiagen N.V. (QGEN)
Form Type6-K
Filed DateJan 13, 2025
Risk Levellow
Pages1
Reading Time1 min
Key Dollar Amounts$300 million
Sentimentbullish

Sentiment: bullish

Topics: shareholder-return, buyback, capital-return

Related Tickers: QGEN

TL;DR

QGEN is buying back $300M in stock via a synthetic repurchase to boost shareholder value.

AI Summary

On January 12, 2025, QIAGEN N.V. announced plans to return approximately $300 million to its shareholders. This will be achieved through a synthetic share repurchase program, which effectively combines a direct capital return with a share buyback mechanism. The company, trading under NYSE: QGEN and Frankfurt Prime Standard: QIA, aims to enhance shareholder value with this initiative.

Why It Matters

This move signals QIAGEN's confidence in its financial position and its commitment to returning capital to investors, potentially boosting shareholder returns.

Risk Assessment

Risk Level: low — The filing is a routine announcement of a capital return plan, not indicating any immediate operational or financial distress.

Key Numbers

Key Players & Entities

FAQ

What is the total amount QIAGEN plans to return to shareholders?

QIAGEN plans to return approximately $300 million to shareholders.

What method will QIAGEN use to return capital to shareholders?

QIAGEN will use a synthetic share repurchase that combines a direct capital return with a share buyback.

On what date was this plan announced?

The plan was announced on January 12, 2025.

What are QIAGEN's stock exchange listings mentioned in the filing?

QIAGEN is listed on the NYSE under the ticker QGEN and on the Frankfurt Prime Standard under the ticker QIA.

What is the purpose of this synthetic share repurchase?

The filing states the purpose is to return capital to shareholders, implying an effort to enhance shareholder value.

Filing Stats: 215 words · 1 min read · ~1 pages · Grade level 9.5 · Accepted 2025-01-13 15:46:36

Key Financial Figures

Filing Documents

Signatures

Signatures 4 Exhibit Index 5 2 Other Information On January 12, 2025, QIAGEN N.V (NYSE QGEN Frankfurt Prime Standard QIA) issued a press release announcing plans to return approximately $300 million to shareholders through a synthetic share repurchase that combines a direct capital repayment with a reverse stock split. The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein. 3

Signatures

Signatures Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. QIAGEN N.V. By s Roland Sackers Roland Sackers Chief Financial Officer Date January 13, 2025 4 Exhibit Index Exhibit No. Exhibit 99.1 Press Release dated January 12, 2025 5

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing